Press Releases

December 16 2010

Research and development in synthetic biology is an evolution of biotechnology innovation that...

September 29 2010

BIO President and CEO Jim Greenwood released the following statement on action by the U.S....

August 24 2010

BIO President and CEO Jim Greenwood issued the following statement today regarding the...

May 24 2010

Achievement of a milestone in creating synthetic life in the form of a self-replicating cell...

March 9 2009

BIO lauded President Barack Obama’s Executive Order to allow the National Institutes of...

June 18 2008

BIO announced today the release of a paper outlining incentives to encourage innovation for...

April 12 2007

Jim Greenwood, President and CEO of the BIO, issued the following statement on S. 5, the Stem...

June 30 1999

 The American Hospital Association and BIO have signed a memorandum of understanding to...

November 12 1998

Carl B Feldbaum, president of  BIO, today issued the following statement on the need for...

July 22 1998

BIO is not surprised to learn that the Roslin Institute has verified the origins of Dolly the...

February 11 1998

Carl B. Feldbaum, president of BIO today issued the following statement after the Senate voted...

January 7 1998

Carl B. Feldbaum, president of BIO, today issued the following statement in response to news...

June 7 1997

Carl B. Feldbaum, president of BIO, issued the following statement today in response to the...

November 20 2013
BIO welcomes the opportunity to provide the views of its members on facilitating access to genetic resources and traditional knowledge and the sharing of benefits from their use...
November 16 2011
Recent reports have raised concerns about how clinical trials are being performed in other countries, particularly in the developing world...
July 7 2009
 BIO thanks the National Institutes of Health (NIH) for the opportunity to submit comments on the advanced notice of proposed rulemaking regarding conflict of interest in federally funded medical research, published in the Federal Register on May 8, 2009...
May 27 2009
The Biotechnology Industry Organization (BIO) thanks the National Institutes of Health (NIH) for the opportunity to submit comments on the draft guidelines for human stem cell research, published in the Federal Register on April 23, 2009...
June 6 2007
As President & CEO of the Biotechnology Industry Organization (BIO), I am writing to express BIO’s support for S. 5, the Stem Cell Research Enhancement Act...
November 17 2011
A timely and consistent regulatory process will ultimately result in medical treatments and cures for some of the most devastating and life-threatening diseases... 
December 16 2010
Research and development in synthetic biology is an evolution of biotechnology innovation that should be supported and encouraged by federal regulatory policies... 
September 29 2010
BIO President and CEO Jim Greenwood released the following statement on action by the U.S. Circuit Court of Appeals last night to stay the lower court’s injunction on federally funded embryonic stem cell research...
August 24 2010
BIO President and CEO Jim Greenwood issued the following statement today regarding the injunction issued yesterday by a U.S. District Court prohibiting the use of federal funds to support embryonic stem cell research...
May 24 2010
Achievement of a milestone in creating synthetic life in the form of a self-replicating cell from synthesized DNA has focused attention on the field of synthetic biology...